{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:05:20Z","timestamp":1771603520310,"version":"3.50.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1093\/qjmed\/hcg097","type":"journal-article","created":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T16:08:13Z","timestamp":1059754093000},"page":"575-578","source":"Crossref","is-referenced-by-count":15,"title":["The interleukin-6 promoter polymorphism in Gaucher disease: a new modifier gene?"],"prefix":"10.1093","volume":"96","author":[{"given":"G.","family":"Altarescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Foldes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Elstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Zimran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2003,8]]},"reference":[{"key":"key\n\t\t\t\t20170413035153_BIB1","unstructured":"Beutler E, Nguyen NJ, Henneberger MW, Smolec JM, McPherson RA, West C, Gelbart T. Gaucher disease: gene frequencies in the Ashkenazi Jewish population. Am J Hum Genet1993; 52:85\u20138."},{"key":"key\n\t\t\t\t20170413035153_BIB2","doi-asserted-by":"crossref","unstructured":"Hollak CE, Corssmit EP, Aerts JM, Endert E, Sauerwein HP, Romijn JA, van Oers MH. Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease. Am J Med1997; 103:185\u201391.","DOI":"10.1016\/S0002-9343(97)00134-4"},{"key":"key\n\t\t\t\t20170413035153_BIB3","doi-asserted-by":"crossref","unstructured":"Stowens DW, Teitelbaum SL, Kahn AJ, Barranger JA. Skeletal complications of Gaucher disease. Medicine (Baltimore)1985; 64:310\u201322.","DOI":"10.1097\/00005792-198509000-00003"},{"key":"key\n\t\t\t\t20170413035153_BIB4","doi-asserted-by":"crossref","unstructured":"Lowik CW, van der Pluijm G, Bloys H, Hoekman K, Bijvoet OL, Aarden LA, Papapoulos SE. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun1989; 162:1546\u201352.","DOI":"10.1016\/0006-291X(89)90851-6"},{"key":"key\n\t\t\t\t20170413035153_BIB5","doi-asserted-by":"crossref","unstructured":"Trindade MC, Lind M, Nakashima Y, Sun D, Goodman SB, Schurman DJ, Smith RL. Interleukin-10 inhibits polymethylmethacrylate particle induced interleukin-6 and tumor necrosis factor-alpha release by human monocyte\/macrophages in vitro. Biomaterials2001; 22:2067\u201373.","DOI":"10.1016\/S0142-9612(00)00376-8"},{"key":"key\n\t\t\t\t20170413035153_BIB6","doi-asserted-by":"crossref","unstructured":"Papadopoulos NG, Georganas K, Skoutellas V, Konstantellos E, Lyritis GP. Correlation of interleukin-6 serum levels with bone density in postmenopausal women. Clin Rheumatol1997; 16:162\u20135.","DOI":"10.1007\/BF02247845"},{"key":"key\n\t\t\t\t20170413035153_BIB7","doi-asserted-by":"crossref","unstructured":"Soutar RL, Dillon JM, Brown D, Ralston SH. Cytokine expression in multiple myeloma and monoclonal gammopathy: analysis by reverse transcription\/polymerase chain reaction and quantitative PCR. Leuk Lymphoma1996; 24:111\u2013120.","DOI":"10.3109\/10428199609045719"},{"key":"key\n\t\t\t\t20170413035153_BIB8","doi-asserted-by":"crossref","unstructured":"Garfinkel D, Sidi Y, Ben-Bassat M, Salomon F, Hazaz B, Pinkhas J. Coexistence of Gaucher\u2019s disease and multiple myeloma. Arch Intern Med1982; 142:2229\u201330.","DOI":"10.1001\/archinte.1982.00340250195035"},{"key":"key\n\t\t\t\t20170413035153_BIB9","doi-asserted-by":"crossref","unstructured":"Allen MJ, Myer BJ, Khokher N, Rushton N, Cox TM. Pro-inflamatory cytokines and the pathgenesis of Gaucher\u2019s disease: increased release of inteleukin-6 and interleukin-10. Q J Med1997; 90:19\u201325.","DOI":"10.1093\/qjmed\/90.1.19"},{"key":"key\n\t\t\t\t20170413035153_BIB10","doi-asserted-by":"crossref","unstructured":"Ferrari SL, Garnero P, Emond S, Montgomery H, Humphries SE, Greenspan SL. A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. Arthritis Rheum2001; 44:196\u2013201.","DOI":"10.1002\/1529-0131(200101)44:1<196::AID-ANR26>3.0.CO;2-5"},{"key":"key\n\t\t\t\t20170413035153_BIB11","doi-asserted-by":"crossref","unstructured":"Zimran A, Sorge J, Gross E, Kubitz M, West C, Beutler E. Prediction of severity of Gaucher\u2019s disease. Lancet1989; 2:349\u201353.","DOI":"10.1016\/S0140-6736(89)90536-9"},{"key":"key\n\t\t\t\t20170413035153_BIB12","doi-asserted-by":"crossref","unstructured":"Dweck A, Blickstein D, Elstein D, Zimran A. Thrombocytosis associated with enzyme replacement therapy in Gaucher disease. Acta Haematol2002; 108:94\u20136.","DOI":"10.1159\/000064744"},{"key":"key\n\t\t\t\t20170413035153_BIB13","doi-asserted-by":"crossref","unstructured":"Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest1998; 102:1369\u201376.","DOI":"10.1172\/JCI2629"},{"key":"key\n\t\t\t\t20170413035153_BIB14","doi-asserted-by":"crossref","unstructured":"Lorentzon M, Lorentzon R, Nordstrom P. Interleukin-6 gene polymorphism is related to bone mineral density during and after puberty in healthy white males: a cross-sectional and longitudinal study. J Bone Miner Res2000; 15:1944\u20139.","DOI":"10.1359\/jbmr.2000.15.10.1944"},{"key":"key\n\t\t\t\t20170413035153_BIB15","doi-asserted-by":"crossref","unstructured":"Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab2003; 88:255\u20139.","DOI":"10.1210\/jc.2002-020092"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/96\/8\/575\/12901361\/hcg097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T20:24:10Z","timestamp":1503519850000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article-lookup\/doi\/10.1093\/qjmed\/hcg097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":15,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2003,8]]},"published-print":{"date-parts":[[2003,8]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcg097","relation":{},"ISSN":["1460-2393","1460-2725"],"issn-type":[{"value":"1460-2393","type":"electronic"},{"value":"1460-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}